Not the same excipients as test
Sponsors
Sanofi-Aventis Recherche & Developpement
Conditions
Colitis UlcerativeCrohn's disease
Phase 2
A Phase 2, multinational, multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate
the efficacy and safety of SAR441566 in adults with moderate-to-severe ulcerative colitis
RecruitingCTIS2025-520705-12-00
Start: 2025-06-24Target: 150Updated: 2025-12-03
A multinational, multicenter extension study to investigate the long-term safety, tolerability and efficacy of balinatunfib in adults with Crohn’s disease or ulcerative colitis
Not yet recruitingCTIS2025-522511-42-00
Target: 2Updated: 2026-03-06